FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016238544> ?p ?o ?g. }

• W2016238544 endingPage "10" @default.
• W2016238544 startingPage "10" @default.
• W2016238544 abstract "Tocilizumab (TCZ), an anti-interleukin-6 receptor antibody, is clinically effective against rheumatoid arthritis (RA), and several reports have indicated how TCZ influences a number of mechanisms underlying RA pathogenesis. However, it is still unclear whether TCZ affects inflammatory cells in peripheral blood and whether any such changes are associated with clinical response. We evaluated associations between proportions of subsets of peripheral immune cells and clinical response in patients with RA treated with TCZ.Thirty-nine consecutive patients with RA who started to receive TCZ as their first biologic between March 2010 and April 2012 were enrolled. The proportions of several subsets of peripheral cells with their levels of expression of differentiation markers, activation markers and costimulatory molecules were measured sequentially from baseline to week 52 by flow cytometry analysis.Clinical Disease Activity Index (CDAI) remission was achieved in 53.8% of patients at week 52 of TCZ therapy. The proportions of CD4(+)CD25(+)CD127(low) regulatory T cells (Treg) and HLA-DR(+) activated Treg cells significantly increased with TCZ therapy (P < 0.001 and P < 0.001, respectively), whereas proportions of CD3(+)CD4(+)CXCR3(-)CCR6(+)CD161(+) T helper 17 cells did not change over the 52 weeks. The proportions of CD20(+)CD27(+) memory B cells, HLA-DR(+)CD14(+) and CD69(+)CD14(+) activated monocytes, and CD16(+)CD14(+) monocytes significantly decreased (P < 0.001, P < 0.001, P < 0.001 and P < 0.001, respectively). Among them, only the change in Treg cells was inversely correlated with the change in CDAI score (ρ = -0.40, P = 0.011). The most dynamic increase in Treg cells was observed in the CDAI remission group (P < 0.001).This study demonstrates that TCZ affected proportions of circulating immune cells in patients with RA. The proportion of Treg cells among CD4(+) cells correlated well with clinical response." @default.
• W2016238544 created "2016-06-24" @default.
• W2016238544 creator A5007888732 @default.
• W2016238544 creator A5019159322 @default.
• W2016238544 creator A5039165431 @default.
• W2016238544 creator A5040489632 @default.
• W2016238544 creator A5050706873 @default.
• W2016238544 creator A5083314956 @default.
• W2016238544 date "2015-01-01" @default.
• W2016238544 modified "2023-10-11" @default.
• W2016238544 title "Peripheral blood CD4+CD25+CD127low regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response" @default.
• W2016238544 cites W132722136 @default.
• W2016238544 cites W1515725948 @default.
• W2016238544 cites W1553772156 @default.
• W2016238544 cites W1592680099 @default.
• W2016238544 cites W1612533388 @default.
• W2016238544 cites W1965827638 @default.
• W2016238544 cites W1969021940 @default.
• W2016238544 cites W1973683306 @default.
• W2016238544 cites W1986543207 @default.
• W2016238544 cites W1991026693 @default.
• W2016238544 cites W2002076761 @default.
• W2016238544 cites W2014081699 @default.
• W2016238544 cites W2027342494 @default.
• W2016238544 cites W2028862182 @default.
• W2016238544 cites W2036010160 @default.
• W2016238544 cites W2037259928 @default.
• W2016238544 cites W2060912271 @default.
• W2016238544 cites W2062006937 @default.
• W2016238544 cites W2091404190 @default.
• W2016238544 cites W2104669609 @default.
• W2016238544 cites W2105487639 @default.
• W2016238544 cites W2110826367 @default.
• W2016238544 cites W2113633952 @default.
• W2016238544 cites W2113702834 @default.
• W2016238544 cites W2123249923 @default.
• W2016238544 cites W2148009861 @default.
• W2016238544 cites W2152348310 @default.
• W2016238544 cites W2155779547 @default.
• W2016238544 cites W2157130851 @default.
• W2016238544 cites W2168822788 @default.
• W2016238544 cites W2171057871 @default.
• W2016238544 cites W2175632479 @default.
• W2016238544 doi "https://doi.org/10.1186/s13075-015-0526-4" @default.
• W2016238544 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4332922" @default.
• W2016238544 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25604867" @default.
• W2016238544 hasPublicationYear "2015" @default.
• W2016238544 type Work @default.
• W2016238544 sameAs 2016238544 @default.
• W2016238544 citedByCount "80" @default.
• W2016238544 countsByYear W20162385442015 @default.
• W2016238544 countsByYear W20162385442016 @default.
• W2016238544 countsByYear W20162385442017 @default.
• W2016238544 countsByYear W20162385442018 @default.
• W2016238544 countsByYear W20162385442019 @default.
• W2016238544 countsByYear W20162385442020 @default.
• W2016238544 countsByYear W20162385442021 @default.
• W2016238544 countsByYear W20162385442022 @default.
• W2016238544 countsByYear W20162385442023 @default.
• W2016238544 crossrefType "journal-article" @default.
• W2016238544 hasAuthorship W2016238544A5007888732 @default.
• W2016238544 hasAuthorship W2016238544A5019159322 @default.
• W2016238544 hasAuthorship W2016238544A5039165431 @default.
• W2016238544 hasAuthorship W2016238544A5040489632 @default.
• W2016238544 hasAuthorship W2016238544A5050706873 @default.
• W2016238544 hasAuthorship W2016238544A5083314956 @default.
• W2016238544 hasBestOaLocation W20162385442 @default.
• W2016238544 hasConcept C126322002 @default.
• W2016238544 hasConcept C203014093 @default.
• W2016238544 hasConcept C2776090121 @default.
• W2016238544 hasConcept C2777178219 @default.
• W2016238544 hasConcept C2777575956 @default.
• W2016238544 hasConcept C2778513237 @default.
• W2016238544 hasConcept C2779727006 @default.
• W2016238544 hasConcept C71924100 @default.
• W2016238544 hasConcept C79484868 @default.
• W2016238544 hasConcept C8891405 @default.
• W2016238544 hasConceptScore W2016238544C126322002 @default.
• W2016238544 hasConceptScore W2016238544C203014093 @default.
• W2016238544 hasConceptScore W2016238544C2776090121 @default.
• W2016238544 hasConceptScore W2016238544C2777178219 @default.
• W2016238544 hasConceptScore W2016238544C2777575956 @default.
• W2016238544 hasConceptScore W2016238544C2778513237 @default.
• W2016238544 hasConceptScore W2016238544C2779727006 @default.
• W2016238544 hasConceptScore W2016238544C71924100 @default.
• W2016238544 hasConceptScore W2016238544C79484868 @default.
• W2016238544 hasConceptScore W2016238544C8891405 @default.
• W2016238544 hasIssue "1" @default.
• W2016238544 hasLocation W20162385441 @default.
• W2016238544 hasLocation W20162385442 @default.
• W2016238544 hasLocation W20162385443 @default.
• W2016238544 hasLocation W20162385444 @default.
• W2016238544 hasOpenAccess W2016238544 @default.
• W2016238544 hasPrimaryLocation W20162385441 @default.
• W2016238544 hasRelatedWork W1557245755 @default.
• W2016238544 hasRelatedWork W1585751203 @default.
• W2016238544 hasRelatedWork W1990002777 @default.
• W2016238544 hasRelatedWork W1997185845 @default.

• next